Biocryst Pharmaceuticals Inc (BCRX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biocryst Pharmaceuticals Inc (BCRX)

BCRX 7.080

+0.7%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: IRWIN JAMES FRANKEL	12/11/2006 10:40:04 AM
	Read Replies (1) of 269

BCRX BioCryst Pharm: Downgrade details (11.32 -0.10) -Update- As mentioned at 9:53, Caris downgraded BCRX to Avg from Above Avg given their view of a marginally higher risk profile for Fodosine in T-cell acute lymphoblastic leukemia and their expectation that the co may need to raise additional capital in the next 12 months.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next